Enhancing patient experience with ambulatory continuous infusion chemotherapy : conversion to an elastomeric infusion device
No Thumbnail Available
Sponsors
Date
Journal Title
Format
poster
Subject
Abstract
"Continuous infusion of parenteral chemotherapy remains a vital component of numerous antineoplastic protocols. Fluorouracil infusions over 46 to 48 hours for the treatment of gastrointestinal malignancies such as colon and pancreatic cancer are among the most common uses of this therapy. Similar approaches are utilized in multiple alternative tumor types including head and neck cancer, bladder cancer, and lymphomas with varying durations and chemotherapy agents. Although these infusions can be administered on an ambulatory basis, the need to utilize a portable infusion device remains cumbersome for patients and can hinder quality of life. There are two basic technologies to accommodate these ambulatory chemotherapy infusions. Electronic devices deliver treatment from a reservoir at a programmed rate whereas elastomeric infusers are governed by the calibrated contraction of a medication filled balloon. Approximately 400 treatments of continuous ambulatory chemotherapy infusions are provided annually at Ellis-Fischel Cancer Center. The traditional practice has been to provide this therapy via electronic infusion devices provided by a third-party vendor."--Background information.
Table of Contents
DOI
PubMed ID
Degree
Thesis Department
Rights
All rights reserved to the author(s) of the poster.